Platinol Related Clinical Trials
Pleurectomy/Decortication With or Without Intraoperative Intrathoracic/Intraperitoneal Heated Cisplatin With Sodium Thiosulfate [Active, not recruiting]
A Study Comparing Irinotecan and Cisplatin (IP) With Etoposide and Cisplatin (EP) Following EP/TRT for LD-SCLC [Active, not recruiting]
Topotecan Plus Cisplatin Versus Etoposide Plus Cisplatin In 1st-Line Extensive Disease Small Cell Lung Cancer [Completed]
Comparative Study of Gemcitabine,Cisplatin and Radiation Versus Cisplatin and Radiation in Cancer of the Cervix [Active, not recruiting]
Phase I Combination With Vinorelbine or Gemcitabine Plus Cisplatin in Locally Advanced or Metastatic NSCLC [Completed]
Pleurectomy/Decortication Followed by Intrathoracic/Intraperitoneal Heated Cisplatin for Malignant Pleural Mesothelioma [Active, not recruiting]
Extrapleural Pneumonectomy With Intraoperative Intrathoracic/Intraperitoneal Heated Cisplatin With Amifostine and Sodium Thiosulfate [Active, not recruiting]
Study Comparing Short Infusion Vs. Fixed Dose of Cisplatin + Gemcitabine in Non Small Cell Lung Cancer. [Completed]
Study of Pemetrexed Plus Cisplatin in Advanced Gastric Cancer [Active, not recruiting]
Safety Trial of IRESSA, Cisplatin and Radiation Therapy for Patients With Head and Neck Cancer [Terminated]
Gemcitabine and Platinol Followed by Pemetrexed and Gemcitabine in Patients With Advanced or Metastatic Bladder Cancer [Completed]
Randomized Trial of Gemcitabine/Cisplatin + PF-3512676 vs Gemcitabine/Cisplatin Alone in Patients With Advanced NSCLC [Active, not recruiting]
TRACE: Tirapazamine-Radiation And Cisplatin Evaluation [Active, not recruiting]
Randomized Phase III Trial of Leukine® Vs Neupogen® in Patients Receiving Cisplatin & Gemcitabine for Urothelial Cancer [Terminated]
Preoperative Cisplatin in Early Stage Breast Cancer [Active, not recruiting]
Efficacy Study of Weekly Topotecan With Cisplatin in Advanced Stage or Recurrent Cervical Cancer [Terminated]
Induction Chemotherapy Comparing Taxotere® Cisplatin and 5-Fluorouracil (TPF) With Standard Cisplatin and 5-Fluorouracil (PF) Followed by Chemoradiation in Locally Advanced Head and Neck Cancer [Completed]
Taxotere, Cisplatin and Irinotecan (CPT-11) for Esophagogastric Cancer [Active, not recruiting]
Study of Taxotere, Cisplatin, 5-Fluorouracil, and Leucovorin for Squamous Cell Carcinoma of the Head and Neck [Completed]
Doxorubicin, Cisplatin, 5-Fluorouracil in Patients With Advanced Adenocarcinoma of the Stomach or Esophagus [Completed]
Gemcitabine Plus Cisplatin Single Dose Versus Split Dose in the Treatment of Patients With Locally Advanced or Metastatic Breast Cancer After Failure of Anthracyclines and/or Taxanes [Completed]
Pharmacogenomic Study of Docetaxel and Cisplatin, Followed by Docetaxel, Cisplatin and Irradiation. [Terminated]
Randomized Multicenter Study Comparing Docetaxel Plus Cisplatin and 5-FU to Cisplatin Plus 5-FU in Advanced Gastric Cancer [Completed]
Docetaxel, Cetuximab and Cisplatin Followed by Radiation, Cetuximab and Cisplatin in Head and Neck Cancer [Active, not recruiting]
Cisplatin and Ifosfamide Combined With Either Paclitaxel or Vinblastine in Treating Men With Progressive or Recurrent Metastatic Germ Cell Tumors [Completed]
Cisplatin and Radiation Therapy With or Without Erlotinib in Treating Patients With Stage III or Stage IV Head and Neck Cancer [Recruiting]
A Phase 3 Trial of LY900003 Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer [Completed]
Gemcitabine, Cisplatin, and Celecoxib Treatment of Metastatic Pancreatic Cancer [Completed]
Cisplatin HAI Study in Patients With Advanced Cancer and Dominant Liver Involvement [Recruiting]
Study of CBP501 + Pemetrexed + Cisplatin in Patients With Solid Tumors (Phase I) and Patients With Malignant Pleural Mesothelioma (Phase II) [Recruiting]
Cisplatin/Vinorelbine/Bevacizumab Followed by Docetaxel/Gemcitabine/Bevacizumab Versus the Cisplatin/Docetaxel/Bevacizumab Combination in Locally Advanced or Metastatic NSCLC [Recruiting]
A Trial Comparing Gemcitabine, Cisplatin and Sorafenib to Gemcitabine, Cisplatin and Placebo in First-Line Treatment of Stage IIIb With Effusion and Stage IV Non-Small Cell Lung Cancer (NSCLC) [Recruiting]
Study Of Irinotecan Hydrochloride (Campto(R)) And Cisplatin Versus Etoposide And Cisplatin In Small Cell Lung Cancer [Recruiting]
Adjuvant Cisplatin With Either Genomic-Guided Vinorelbine or Pemetrexed for Early Stage Non-Small Cell Lung Cancer [Recruiting]
Gemcitabine and Cisplatin (GC) Plus Sorafenib in Chemotherapy-naïve Patients With Locally Advanced or Metastatic Urothelial Carcinoma [Recruiting]
Cisplatin as First Line Therapy for Triple-Negative Metastatic Breast Cancer and Evaluation of p63/p73 as a Biomarker Response [Recruiting]
Docetaxel Plus Cisplatin Followed by Gemcitabine Versus Gemcitabine Plus Cisplatin Followed by Docetaxel for Non-Small Cell Lung Cancer (NSCLC) [Recruiting]
Extrapleural Pneumonectomy, IHOC Cisplatin and Gemcitabine With Amifostine and Sodium Thiosulfate Cytoprotection for Resectable Malignant Pleural Mesothelioma [Recruiting]
Phase III Study of S-1 + Cisplatin vs Cisplatin in Cervical Cancer [Recruiting]
Methotrexate, Vinblastine, Doxorubicin and Cisplatin (MVAC) Followed by Gemcitabine Plus Cisplatin (GEM+CDDP) in Locally Advanced or Metastatic Bladder Cancer [Recruiting]
CPT-11/Cisplatin and Celecoxib With Radiation Therapy for Patients With Unresectable Non-Small Cell Lung Cancer (NSCLC) [Recruiting]
A Study of Weekly Docetaxel Plus Cisplatin Followed by Gemcitabine vs. Gemcitabine Plus Cisplatin Followed by Weekly Docetaxel in the Treatment of Advanced Non-Small-Cell Lung Cancer [Recruiting]
Study of Amrubicin With or Without Cisplatin Versus Etoposide-Cisplatin for Extensive Stage Small Cell Lung Cancer [Recruiting]
A Study To Find The Best Dose Of SU011248 When Given With Pemetrexed, Pemetrexed And Cisplatin Or Pemetrexed And Carboplatin In Patients With Advanced Solid Tumors [Recruiting]
Maximum Tolerated Dose LeveL (MTD) of ZD6474 With Radiation or Concomitantly With Weekly Cisplatin and Radiation Therapy, Stage III-IV HNSCC [Recruiting]
Study of Docetaxel, Cisplatin, and Fluorouracil (Modified DCF) With Bevacizumab in Patients With Unresectable or Metastatic Gastroesophageal Adenocarcinoma [Recruiting]
A Study Comparing Etoposide/Cisplatin With Irinotecan/Cisplatin to Treat Extensive Disease Small Lung Cancer [Recruiting]
Dose Escalation Trial of Neoadjuvant Sorafenib and Concurrent Sorafenib, Cisplatin and Radiation in Locally Advanced Squamous Cell Carcinomas of the Head and Neck (SCCHN) [Not yet recruiting]
Randomized Study of Gemcitabine and Cisplatin With or Without Cetuximab in Urothelial Cancer [Recruiting]
Irinotecan Plus Cisplatin vs Pemetrexed Plus Cisplatin as 2nd Line in NSCLC Stage IIIB/IV [Recruiting]
Study to Determine the Maximum Tolerated Dose of BIBW 2992 (TOVOK) When Combined With Cisplatin/Paclitaxel or Cisplatin/5-FU in Patients With Advanced Solid Tumours [Recruiting]
Cetuximab, Cisplatin, and Irinotecan in Treating Patients With Metastatic Esophageal Cancer, Gastroesophageal Junction Cancer, or Gastric Cancer That Did Not Respond to Previous Irinotecan and Cisplatin [Recruiting]
Induction Therapy-Docetaxel, Cisplatin and Fluorouracil in Untreated Patients With Advanced Squamous Cell or Undifferentiated Carcinoma of the Paranasal Sinuses [Recruiting]
Phase3 Study of Amrubicin With Cisplatin Versus Etoposide-Cisplatin for Extensive Disease Small Cell Lung Cancer [Recruiting]
Trial on Refinement of Early Stage Lung Cancer Adjuvant Therapy [Recruiting]
Phase I Clinical and Pharmacokinetic (PK) Study of CBP501 and Cisplatin Every 3 Weeks in Patients With Advanced Refractory Solid Tumors [Recruiting]
Study Of CP-751,871 In Combination With Cisplatin And Gemcitabine In Chemotherapy-Naïve Patients With Advanced Non-Small Cell Lung Cancer [Recruiting]
Intravenous and Intraperitoneal Paclitaxel, Intraperitoneal Cisplatin, and Intravenous Bevacizumab for the Initial Treatment of Optimal Stage II or III Ovarian, Primary Peritoneal, and Fallopian Tube Cancer [Recruiting]
Lapatinib, Cisplatin, Gemcitabine as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urothelial Cancer [Recruiting]
Study for Patients With Advanced, Not Amenable to Surgery, or Metastatic Lung Cancer Comparing Treatment With Pemetrexed + Cisplatin + Enzastaurin Versus Pemetrexed + Cisplatin + Placebo [Recruiting]
Cisplatin and Radiation Therapy With or Without Tirapazamine in Treating Patients With Cervical Cancer [Recruiting]
Study of Radiation Therapy and Concurrent Cisplatin Chemotherapy in the Treatment of Locally Advanced or Metastatic Malignant Melanoma [Recruiting]
Trial of 2 Cycles of Induction Chemo With Abraxane, Cetuximab, Cisplatin, & 5-FU for Advanced Head and Neck Cancer [Recruiting]
Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin for Children With Peritoneal Cancer [Recruiting]
Cisplatin, Pemetrexed, and Imatinib Mesylate in Malignant Mesothelioma [Recruiting]
Enoxaparin Low Molecular Weight Heparin (LMWH) in Advanced Non Small Cell Lung Cancer: Effect on Survival and Symptom Control in Patients Undergoing First Line Chemotherapy (SYRINGES) [Recruiting]
IMRT Plus Cisplatin Versus Conventional Radiotherapy Plus Cisplatin in Stage III-IV HNSCC [Recruiting]
Phase I Safety and Tolerability Study of Cediranib (RECENTINâ„¢, AZD2171) in Combination With Chemo in First Line Lung Cancer Patients [Recruiting]
TPF Plus Cisplatin and Radiotherapy vs TPF Plus Cetuximab and Radiotherapy to Treat Head and Neck Cancer. [Recruiting]
Randomized Study of Cisplatin-Etoposide Versus an Etoposide Regimen Without Cisplatin in Extensive Small-Cell Lung Cancer [Recruiting]
Larotaxel + Cisplatin Versus Gemcitabine + Cisplatin in First Line Treatment of Locally Advanced/Metastatic Urothelial Tract or Bladder Cancer [Recruiting]
Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) With Growth Factor Support in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma [Recruiting]
Preoperative Cisplatin and Bevacizumab in ER-, PR-, Her-2 Negative Breast Cancer [Recruiting]
Evaluation Of The Efficacy Of The Combination Of Axitinib With Pemetrexed And Cisplatin In The Treatment Of Non-Squamous Non-Small Cell Lung Cancer [Not yet recruiting]
Phase I/II AZD2281/Cisplatin in Neoadjuvant Treatment of Triple Negative Breast Cancer Patients [Not yet recruiting]
Cisplatin, Gemcitabine and Bevacizumab in Combination for Metastatic Transitional Cell Cancer [Recruiting]
Oral Chemotherapy And Platinum With Radiotherapy Followed Or Not By Consolidation With The Same Chemotherapy In Locally Advanced Non Small Cell Lung Cancer [Recruiting]
Irinotecan and Cisplatin for High Grade Neuroendocrine Carcinoma of the Gastrointestinal Tract [Recruiting]
Cisplatin and Everolimus in Treating Patients With Advanced Solid Tumors or Recurrent or Metastatic Head and Neck Cancer [Recruiting]
Cetuximab and Cisplatin in the Treatment of "Triple Negative" (Estrogen Receptor Negative, Progesterone Receptor Negative, and HER2 Negative) Metastatic Breast Cancer [Recruiting]
Low-Dose RAD001(Everolimus) Plus Cisplatin-HDFL Chemotherapy for the First-Line Treatment of Advanced Gastric Cancer [Recruiting]
Gemcitabine and Cisplatin for Advanced or Recurrent Endometrial Cancer [Recruiting]
A Phase II Study of Intra-Arterial Chemotherapy With Cisplatin and Mitomycin-C in Patients With Hepatocellular Carcinoma [Recruiting]
Feasibility Study of CDDP + CPT-11 + PSK for Extensive-Stage Disease (ED) Small Cell Lung Cancer [Recruiting]
|
